マサチューセッツ州におけるアミロイドーシスの臨床試験
マサチューセッツ州内の拠点で、アミロイドーシスに関する11件の研究が参加者を募集しています。
マサチューセッツ州内の都市
公式研究テキスト（英語）
Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis
- Research Site, Boston
- Research Site, Boston
- Research Site, Boston
被験者募集中観察研究
18歳〜130歳 · 全性別 · 2026/09/23更新 · NCT06465810TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
- Clinical Trial Site, Boston
- Clinical Trial Site, Boston
被験者募集中第3相
18歳〜85歳 · 全性別 · 2026/09/16更新 · NCT07052903TRITON-PN: A Study to Evaluate the Efficacy and Safety of Nucresiran in Patients With Hereditary Transthyretin Amyloidosis With Polyneuropathy
- Clinical Trial Site, Boston
被験者募集中第3相
18歳〜85歳 · 全性別 · 2026/09/15更新 · NCT07223203DemonsTTRate: A Global, Observational, Multicenter, Long-term Study of Patients With ATTR-CM in a Real-World Setting
- Clinical Trial Site, Boston
被験者募集中観察研究
18歳以上 · 全性別 · 2026/09/09更新 · NCT07358078Prevalence and Prediction of ATTR in Ambulatory Patients With HFpEF
- Massachusetts General Hospital, Boston
被験者募集中
65歳以上 · 全性別 · 2026/09/01更新 · NCT05577819Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
- Massachusetts General Hospital, Boston
- Brigham and Women's Hospital, Boston
- Boston University (BU) School of Medicine, Boston
被験者募集中第3相
18歳〜75歳 · 全性別 · 2026/08/04更新 · NCT06563895[64Cu]FBP8 PET for Early Detection of Intracardiac Thrombus in Amyloid Cardiomyopathy
- Brigham and Women's Hospital, Boston
被験者募集中第3相
18歳以上 · 全性別 · 2026/07/21更新 · NCT07560306A Phase 1b/2 Study of CAR T Cell Therapy Targeting CD19 and BCMA in Participants With Relapsed or Refractory AL Amyloidosis.
- Research Site, Boston
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/07/02更新 · NCT07081646A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Immunoglobulin Light Chain (AL) Amyloidosis Receiving Etentamig (ABBV-383) as an Intravenous (IV) Infusion
- Boston Medical Center /ID# 255066, Boston
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/05/13更新 · NCT06158854MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)
- Brigham and Women's Hospital, Boston
- Boston University School of Medicine, Boston
被験者募集中第3相
18歳〜90歳 · 全性別 · 2026/03/27更新 · NCT06128629Molecular Imaging of Primary Amyloid Cardiomyopathy
- Brigham and Womens' Hospital, Boston
被験者募集中
18歳〜99歳 · 全性別 · 2025/11/14更新 · NCT02641145ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。